MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10620-025-09630-7

Медицинская библиотека · Digestive diseases and sciences · 2026

Eosinophilic Ascites: An Underrecognized Entity in Peritoneal Disorders.

Chowdhary Rishi, Awan Zainab, Sheth Param Darpan, Reyaz Ibrahim

СтатьяОбзорПеревод в очереди

Аннотация

BACKGROUND

Eosinophilic ascites (EA) is a rare, under-recognized condition characterized by eosinophil-rich peritoneal fluid, most frequently associated with eosinophilic gastroenteritis (EGE). Its true prevalence is unclear, often misdiagnosed as malignancy, tuberculosis, or cirrhosis. EA typically presents between ages 30 and 50, with slight male predominance. Its clinical importance lies in a favorable response to corticosteroids and the potential for severe complications such as intestinal obstruction if untreated.

OBJECTIVE

This review consolidates current knowledge on EA, focusing on its etiology, pathophysiology, diagnostic challenges, and treatment strategies, while highlighting key knowledge gaps.

METHODS

A narrative review was conducted using PubMed, SpringerLink, and Web of Science (2000-2025). Search terms included "eosinophilic ascites," "eosinophilia," and "ascitic fluid." Included studies reported histopathologically confirmed EA with ascitic eosinophilia > 10%, imaging data, and treatment outcomes. Case reports lacking confirmatory paracentesis or biopsy were excluded. Data on demographics, clinical presentation, fluid analysis, imaging, etiology, treatment, and outcomes were extracted independently by two reviewers.

RESULTS

EA pathogenesis involves IL-5-driven eosinophilic infiltration of the gastrointestinal serosa. Diagnostic features include exudative ascites (protein > 2.5 g/dL) with eosinophilic predominance (60-90%), peripheral eosinophilia (85%), and CT evidence of bowel wall thickening (72%). Corticosteroids (0.5-1 mg/kg/day) achieve remission in 80% within two weeks; anti-IL-5 agents may benefit refractory cases. Significant gaps include absent diagnostic biomarkers and unknown relapse rates.

CONCLUSION

EA demands heightened clinical suspicion in eosinophilic ascites. Future priorities include the development of non-invasive diagnostics, trials comparing biologics with steroids, and the exploration of genetic mutations in refractory disease.

Для цитирования: Chowdhary Rishi, Awan Zainab, Sheth Param Darpan, Reyaz Ibrahim. Eosinophilic Ascites: An Underrecognized Entity in Peritoneal Disorders.. Digestive diseases and sciences. 2026. DOI: 10.1007/s10620-025-09630-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.